Shares of Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report) were down 47.9% on Tuesday . The company traded as low as $1.30 and last traded at $1.35. Approximately 1,200 shares traded hands during trading, a decline of 58% from the average daily volume of 2,886 shares. The stock had previously closed at $2.59.
Idorsia Price Performance
The firm has a 50-day moving average price of $2.55 and a 200-day moving average price of $2.42.
About Idorsia
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Read More
- Five stocks we like better than Idorsia
- Earnings Per Share Calculator: How to Calculate EPS
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- What is MarketRankā¢? How to Use it
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Top Stocks Investing in 5G Technology
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.